SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-346916
Filing Date
2021-12-03
Accepted
2021-12-02 18:37:32
Documents
13
Period of Report
2021-12-02
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d204123d8k.htm   iXBRL 8-K 29594
  Complete submission text file 0001193125-21-346916.txt   183116

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dyn-20211202.xsd EX-101.SCH 3218
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyn-20211202_def.xml EX-101.DEF 13253
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyn-20211202_lab.xml EX-101.LAB 21807
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyn-20211202_pre.xml EX-101.PRE 14050
6 EXTRACTED XBRL INSTANCE DOCUMENT d204123d8k_htm.xml XML 4769
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 211468166
SIC: 2834 Pharmaceutical Preparations